Axa
WVE icon

Axa’s Wave Life Sciences WVE Stock Holding History

Axa’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61,100
Closed -$519K – 1361
2020
Q3 		$519K Sell
61,100
-6,200
-9% -$68K ﹤0.01% 1032
2020
Q2 		$701K Buy
+67,300
New +$633K ﹤0.01% 1010

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa's WVE Position: Q4 2020 in Review

Axa sold out of Wave Life Sciences (WVE) in Q4 2020, closing a stake of 61,100 shares — an estimated $519K sold.

Axa first reported a position in WVE in Q2 2020 and held it in 2 quarters. The position peaked at $701K in Q2 2020. 108 funds tracked by Wall St. Rank hold WVE as of Q4 2020.

  • Axa reported no remaining Wave Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Axa sold 61,100 Wave Life Sciences shares in Q4 2020, an estimated $519K.
  • Axa first reported a position in Wave Life Sciences in Q2 2020 and held it in 2 quarters.
  • Axa's Wave Life Sciences position peaked at $701K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.